Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
916.25
-10.90 (-1.18%) Natco Pharma informs about press release
Date: 02-09-2021Natco Pharma has informed that it enclosed a press release on 2nd September 2021 titled ‘Natco Pharma (Canada) Inc. announces the launch of PrNAT-LENALIDOMIDE Capsules, the first generic alternative to Revlimid®’ under Regulation 30 of SEBI (LODR) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.